Top 10 Clinical Research Organisations in the Pharma and Biotech Industry: Syneos Health
Founded in 1999, Syneos Health is the only end-to-end fully integrated biopharmaceutical solutions organisation
Pharma IQ presents the top 10 ranking of Contract Research Organizations as voted by the Pharma IQ network. Click here to see the whole list
Founded in 1999, Syneos Health is the only end-to-end fully integrated biopharmaceutical solutions organisation. Syneos health has a global footprint with over 110 offices located in Europe, North America, Latin America, the Middle East, Africa, and the Asia-Pacific.
Syneos Health has three segments, Contract Research Organisation (CRO) and Contract Commercial Organisation (COO), both of which offer various solutions to accelerate client performance. In addition, it also offers consulting services to its clients.
Clinical Solutions – The clinical solutions segment provides fit-for-purpose solutions from spanning Phase I to Phase IV, including biostatistics and statistical programming, data management, clinical staffing, quality risk management and more.
Commercial Solutions – In the commercial solutions segment, Syneos Health offers solutions to improve brand performance through leveraging data and insights. The company has a very broad range of commercialization services suited to businesses of all size,
Consulting – Syneos Health also has a wide variety of advisory services, offering insight on market access, brand commercialisation, portfolio strategy, commercial models of the future and more.
- Syneos Health was created after the merger of two industry-leading biopharmaceutical companies, INC Research and inVentive health.
- In 2018, the company rebranded from INC Research/inVentiv Health to Syneos Health. The brand change reflected the successful integration of its Contract Research Organization (CRO) sector, and the Contract Commercial Organization (CCO) sector.
- On June 2018, Syneos Health announced a strategic collaboration with Elligo, a platform that brings clinical research to direct clinical health care. The collaboration is slated to entail the creation of a centrally managed infrastructure around patients and physicians who have not been able to access traditional sites.
Headquarters: North Carolina, United States
CEO: Alistair Macdonald– October 2016
Estimated revenue: $2.5 B (2017)